Our Recommendations
- Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika (2023)
- Prise en charge d’une épidémie de choléra (2018)
- Management of a cholera epidemic (Arabic) (2017)
- Handbook For Clinical Management Of Dengue (2012)
- Manuel pour les soins et la prise en charge des patients dans les centres de soins communautaires (2015)
New Publications
- Multi-country outbreak of mpox, External situation report #42- 9 November 2024 (2024)
- Considerations for border health and points of entry for mpox: interim guidance (2024)
- Operational guidance on the use of yellow fever assays in the context of surveillance (2023)
- Issue Brief: Mpox Update (2024)
- Mpox Outbreak: Short Case Report Form (2023)
Filter
123
Featured
Recommendations
26
New Publications
30
Language
Document type
No document type
54
Guidelines
35
Studies & Reports
12
Fact sheets
8
Resource Platforms
6
Training Material
3
Infographics
2
Manuals
1
Situation Updates
1
Online Courses
1
Countries / Regions
Nigeria
6
Guinea
4
Germany
4
Sierra Leone
3
Congo, Democratic Republic of
3
Brazil
3
Liberia
3
Madagascar
3
Senegal
2
Burkina Faso
2
Côte d’Ivoire / Ivory Coast
2
South Africa
2
Rwanda
1
Peru
1
Mozambique
1
Global
1
Dominican Republic
1
Paraguay
1
United Kingdom
1
Mali
1
Angola
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
26
Diarrhoeal Disease/Cholera
9
Yellow Fever
9
Guidelines
7
Yersinia pestis (Plague)
6
Dengue
6
Virology
4
NTDs & Others
4
Pediatrics
3
Vaccine-preventable Diseases
3
Zika
2
Paediatrics
2
Emergency Health Kits
2
x MEDBOX Issue Brief & Annual Reports x
2
Hemorrhagic Fever
2
Clinical Guidelines
2
Diarrhoea
2
Respiratory Infections
2
Disease Prevention & Control
2
Bacteriology
1
General Guidelines
1
Monitoring & Evaluation
1
NCD
1
WASH
1
Surgery & Anaesthesia
1
Toolboxes
MPOX - Monkeypox
48
Cholera
16
Influenza
12
MPOX - Monkeypox
12
Dengue
10
Cholera Prevention & Control
9
MPOX -Monkeybox Prevention & Control
9
Chikungunya
9
Yellow Fever
8
Treatment Guidelines
7
Plague
7
Ebola
7
Zika
7
Plague Prevention & Control
5
Treatment Guidelines
4
Clinical Guidelines
4
Diarrhoea
4
Outbreak Prevention & Control
3
Clinical Guidelines
3
Ebola Prevention & Control
3
Infection Control
3
Public Health
3
WASH
3
Laboratory & Diagnostics
3
Surveillance
2
Yellow Fever Prevention & Control
2
Influenza Prevention & Control
2
Training
2
Training Material
2
Cholera
2
Emergency health kits
2
Dengue & Chikungunya
2
Dengue Prevention & Control
2
Other Resources
2
Meningitis & Encephalitis
2
Gynaecology / Obstetrics
1
Communication & Training
1
Laboratory Guidance
1
IPC
1
Context, Facts & Travel Advice
1
Children
1
Key Resources
1
Ebola & Marburg
1
Laboratory & Sampling
1
PPE Personel Protective Equipment
1
Context & Facts
1
Prevention & Preparedness
1
Risk Communication & Community Engagement
1
Psychosocial Support
1
Essential Medicines & Devices Lists
1
Online Courses
1
Guidelines & Manuals
1
Emergency health kits
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
War Surgery & Wound Care
1
Neurological Disorders
1
Zika
1
Malnutrition
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Paediatrics
1
Preparedness & Prevention
1
Case Definitions
1
Pregnant women
1
Public Health
1
Capacity Building
1
Preparedness & Prevention
1
Cholera epidemics continue to be a major public health problem in many countries around the
world. When epidemics strike, they can spread rapidly. The disease can also evolve quickly;
patients with severe disease can die of dehydration hours after showing the first symptoms of
cholera.
Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exanthema, headache or retro-orbital pain, myalgia or ar...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
ver the past 15 years, dengue fever, an endemic disease in the country, has triggered significant epidemics in 2010, 2019, and most recently in 2023. This year, due to the escalating number of reported cases, the Secretariat of Health (SESAL) issued an epidemiological alert in February. By March, th...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for dengue fever outbreaks. The toolkit conta...
The monkeypox virus (MPXV) clade I epidemic that has been affecting the Democratic Republic of the Congo
(DRC) since November 2023 has recently spread to several other African countries including Burundi, Rwanda,
Uganda and Kenya. The size of these outbreaks could be larger than reported due to un...
L’orthopoxvirus simien ou virus de la variole du singe (MPXV), est un virus à ADN double brin qui appartient au genre Orthopoxvirus de la famille
des Poxviridés. Les poxvirus causent des maladies chez l’espèce humaine et beaucoup d’autres animaux ; l’infection se manifeste généralement...
Patient's Guide
Resource Platform
Infographic
WHO has updated the mpox Case reporting form (CRF) and data collection tool, mainly by reducing the number of variables. A detailed list of changes is presented in the file. The content of the Case investigation form (CIF) has not been changed.
Issue Brief 39
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
